Preface |
|
v | |
Acknowledgements |
|
v | |
|
Role of intracellular signalling in cerebral ischemia |
|
|
1 | (42) |
|
Expression of PTEN and its phosphorylated form after transient middle cerebral artery occlusion in rat |
|
|
3 | (10) |
|
|
|
|
|
|
|
|
|
|
|
CRE-mediated gene expression in cerebral ischemia |
|
|
13 | (8) |
|
|
|
|
|
|
|
|
|
Poly (ADP-ribose) polymerase and brain ischemia |
|
|
21 | (10) |
|
|
|
|
|
|
|
Effect of angiotensin II on cerebral edema following cerebral ischemia and reperfusion |
|
|
31 | (12) |
|
|
|
|
Genes and genetic models of cerebral ischemia |
|
|
43 | (48) |
|
High-density DNA microarray analysis of gene expression following transient focal cerebral ischemia in mouse |
|
|
45 | (12) |
|
|
|
|
|
|
Hypoxic induction of vascular endothelial growth factor is impaired in the spinal cord of the mice with mutant human SODI gene |
|
|
57 | (8) |
|
|
|
|
|
|
|
|
Early decrease of survival signal protein and DNA repair enzyme in spinal motor neuron of presymptomatic transgenic mice with a mutant SODI gene |
|
|
65 | (8) |
|
|
|
|
|
|
|
|
Alteration in survival signal induction by transient hypoxia in mice expressing mutant human SODI protein |
|
|
73 | (10) |
|
|
|
|
|
|
|
Renin-angiotensin system gene polymorphism in Japanese stroke patients |
|
|
83 | (8) |
|
|
|
|
|
|
|
|
|
Neuroprotection with hypothermia and against inflammation |
|
|
91 | (62) |
|
Mild hypothermia enhances efficacy of neuroprotective agents in cerebral ischemia in rats |
|
|
93 | (10) |
|
|
|
Effects of aging on hypothermic neuroprotection in acute stroke |
|
|
103 | (6) |
|
|
|
|
|
The effects of a free radical scavenger, edaravone, combined with mild hypothermia on ischemic brain damage following transient middle cerebral artery occlusion in rats |
|
|
109 | (8) |
|
|
|
|
|
|
Immunophilin ameliorates apoptotic neuronal cell death |
|
|
117 | (6) |
|
|
|
Expression of FKBP12 after brain ischemia |
|
|
123 | (6) |
|
|
Effects of FK506 on chronic cerebral hypoperfusion-induced discrimination learning disabilities in Wistar rats |
|
|
129 | (6) |
|
|
|
|
FK506 facilitates the normalization of post-ischemic perturbation of protein kinases and tyrosine phosphorylation in the gerbil hippocampal CA1 sectors |
|
|
135 | (6) |
|
|
|
|
|
|
Nuclear factor-kappa B decoy protects spinal cord injury following ischemia reperfusion in rats |
|
|
141 | (6) |
|
|
|
|
|
|
|
|
Functional modulation of astrocytes by a novel agent ONO-2506 mitigates delayed infarct expansion with a wide therapeutic time window, inducing prompt neurological recovery through reduction of the extracellular level of glutamate |
|
|
147 | (6) |
|
|
|
|
|
|
|
|
Molecular mechanisms and therapy for ischemic brain damage |
|
|
153 | (80) |
|
Caspases and upstream mechanisms in central nervous system ischemic injury |
|
|
155 | (8) |
|
|
|
|
Spatiotemporal changes of free cholesterol and neutral lipids after transient focal cerebral ischemia in rats |
|
|
163 | (8) |
|
|
|
|
|
|
|
|
|
Apolipoprotein E influences neuronal death and repair |
|
|
171 | (8) |
|
|
|
|
|
Suppression of protein synthesis after transient cerebral ischemia |
|
|
179 | (14) |
|
|
|
|
New vessel formation and expression of angiogenesis-related genes in brain after ischemia |
|
|
193 | (10) |
|
|
|
Therapeutic time window of rt-PA on embolic stroke in rat |
|
|
203 | (6) |
|
|
|
|
|
|
|
|
|
Expression of LOX-1 in spontaneously hypertensive rat carotid atherosclerotic lesions |
|
|
209 | (4) |
|
|
|
|
|
|
|
Expression of p-ERK and cytochrome C signals in rat brain neurons after transient MCAO |
|
|
213 | (8) |
|
|
|
|
|
|
|
|
|
Protection against ischemic brain damage by GDNF affecting cell survival and death signals |
|
|
221 | (12) |
|
|
|
|
|
|
|
|
Neurotrophic factors and gene therapy for stroke |
|
|
233 | (64) |
|
Neuroprotection by drug-induced growth factors |
|
|
235 | (12) |
|
|
|
Neurotrophic factor delivery by encapsulated cell grafts |
|
|
247 | (6) |
|
|
|
|
Gene therapy for cerebral arteries |
|
|
253 | (6) |
|
|
|
Therapeutic time window of glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat |
|
|
259 | (6) |
|
|
|
|
|
|
Therapeutic time window of Ad-GDNF after transient middle cerebral artery occlusion in rat |
|
|
265 | (10) |
|
|
|
|
|
|
Attenuation of neuronal cell death by SOD1 is associated with extracellular signal-regulated kinase after transient focal cerebral ischemia in mice |
|
|
275 | (10) |
|
|
|
|
|
|
|
|
Adenovirus-mediated gene transfer to ischemic brain |
|
|
285 | (6) |
|
|
|
|
|
|
The change of distribution and mRNA expression of brain-derived neurotrophic factor after intrastriatal hemorrhage |
|
|
291 | (6) |
|
|
|
|
|
|
Imaging of brain function |
|
|
297 | (48) |
|
Assessment of neuroreceptor changes in healthy ageing and in Alzheimer's disease with emission tomography |
|
|
299 | (10) |
|
|
MR imaging in acute stroke |
|
|
309 | (6) |
|
|
New MEG technology for evaluating focal brain function |
|
|
315 | (6) |
|
|
|
|
|
|
Imaging of remote areas after focal cerebral ischemia |
|
|
321 | (8) |
|
|
|
|
|
|
Propagation of recurrent depolarization in the penumbra in the rat---use of in vivo cortical NADH fluorescence |
|
|
329 | (8) |
|
|
|
|
Quantitative aspects of neurovascular interaction |
|
|
337 | (4) |
|
|
Predicting the pathological fate of focal cerebral ischemia using 1H-magnetic resonance spectroscopic imaging |
|
|
341 | (4) |
|
|
|
|
|
|
Molecular mechanism of Alzheimer's disease and the therapeutic potentials |
|
|
345 | (72) |
|
Distinct functions of tau isoforms in Alzheimer's disease |
|
|
347 | (8) |
|
|
|
|
|
γ-Cleavage and ε-cleavage of β-amyloid precursor protein |
|
|
355 | (8) |
|
|
|
COX-2 expression in brains of patients with familial Alzheimer's disease |
|
|
363 | (10) |
|
|
|
|
|
|
|
|
Accumulation of amyloid β protein in Tg2576 mice |
|
|
373 | (6) |
|
|
|
|
|
|
Molecular pathology of transgenic tau mice |
|
|
379 | (4) |
|
|
|
|
|
|
Heat shock proteins reduce aggregation and facilitate degradation of tau protein |
|
|
383 | (12) |
|
|
|
|
|
Alzheimer's disease and melatonin |
|
|
395 | (4) |
|
|
|
|
|
|
Aβ42 vaccine on the Tg2576 Alzheimer model mice |
|
|
399 | (6) |
|
|
|
|
|
|
|
|
|
|
Aβ vaccination of a genetic model of Alzheimer's disease |
|
|
405 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Somatosensory-evoked fields in Alzheimer's disease |
|
|
411 | (6) |
|
|
|
|
|
|
|
|
|
Activation of stem cell in ischemic brain |
|
|
417 | (42) |
|
Highly polysialylated neural cell adhesion molecule positive cells increased and changed localization in rat hippocampus with exposure to repeated kindled seizures |
|
|
419 | (8) |
|
|
|
|
|
|
|
|
|
Activation of neural stem cells after global brain ischemia |
|
|
427 | (8) |
|
|
|
|
|
|
|
|
|
|
Activation and proliferation of oligodendrocyte progenitor cells after brain ischemia in the rat |
|
|
435 | (10) |
|
|
|
|
|
|
|
Cyclooxygenase-2 is involved in increased proliferation of neuronal progenitor cells in the ischemic mouse hippocampus |
|
|
445 | (6) |
|
|
|
|
|
|
|
|
|
|
Comparison of proliferation of oligodendrocyte progenitor cells between young and aged rats after transient cerebral ischemia |
|
|
451 | (8) |
|
|
|
|
|
|
|
|
Stem cell therapy for ischemic brain |
|
|
459 | (40) |
|
Differentiation of bone marrow cells in culture and in vivo |
|
|
461 | (4) |
|
|
|
|
|
|
Treatment of stroke with marrow stromal cells |
|
|
465 | (6) |
|
|
|
Transplantation of mesenchymal stem cells derived from the bone marrow into the demyelinated spinal cord |
|
|
471 | (6) |
|
|
|
|
|
|
|
Transplantation of neural stem cells into ischemic brain |
|
|
477 | (6) |
|
|
Cell therapy for cerebral ischemia using vascular endothelial growth factor-secreting cells |
|
|
483 | (6) |
|
|
|
|
|
|
|
|
Transplantation of neural stem cells into epileptic brain |
|
|
489 | (4) |
|
|
|
|
|
|
|
|
|
|
|
Neural stem cells as therapeutic agents for CNS injuries and disorders |
|
|
493 | (6) |
|
Author index |
|
499 | (4) |
Keyword index |
|
503 | |